PCR-detected genome polymorphism in malignant cell growth.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Genetic polymorphism plays a key role in tumorigenesis, influencing fundamental tumor capacities.
• Understanding DNA polymorphism is vital for assessing oncogenes, antioncogenes, and apoptosis-related genes.
• A specific type of DNA polymorphism, the microsatellite mutator phenotype, arises from increased mutations in cancer cell genomes.

Purpose of the Study:

• To analyze genetic polymorphism in tumorigenesis and its impact on tumor characteristics.
• To investigate the association between DNA polymorphism and the status of key cancer-related genes.
• To explore the prognostic significance of DNA polymorphism in benign and malignant tumors.

Main Methods:

• Utilizing modified Polymerase Chain Reaction (PCR) methods for detecting genome polymorphism in tumor cells.
• Employing a modified B1-PCR technique to study genome polymorphism in mouse tumor cells.
• Analyzing DNA fingerprints to identify changes associated with tumor development and differentiation.

Main Results:

• Modified PCR successfully detected various forms of polymorphism in tumor cells.
• A gain of a 470 bp band and loss of a 600 bp band were observed in MH-22a hepatoma cells compared to normal mouse liver cells.
• No significant DNA fingerprint changes were noted during the differentiation of teratocarcinoma EC F9 cells.

Conclusions:

• DNA polymorphism analysis, including the microsatellite mutator phenotype, is crucial for understanding tumor biology and prognosis.
• Modified PCR techniques offer valuable tools for detecting and analyzing genetic alterations in cancer.
• Further analysis of DNA polymorphism in diverse tumor types will advance both theoretical cancer research and clinical oncology.